Antidepressant medication use in palliative care

2006 ◽  
Vol 23 (2) ◽  
pp. 127-133 ◽  
Author(s):  
Karl E. Miller ◽  
Stephen M. Adams ◽  
Martha M. Miller
1999 ◽  
Vol 9 (5) ◽  
pp. 283-289 ◽  
Author(s):  
Michelle Cotterchio ◽  
Nancy Kreiger ◽  
Gerarda Darlington ◽  
Allan Steingart

2020 ◽  
Vol 7 (2) ◽  
pp. 205510292097771
Author(s):  
Kathleen Kenney-Riley ◽  
Shari Salzhauer Berkowitz ◽  
Kimberly Rapoza

The current study examines depression and pain as potential contributors to patient-provider discordance in the assessment of lupus disease activity. The study conducted a secondary analysis of data obtained from the Childhood Arthritis and Rheumatology Research Alliance registry, with N = 859 adolescent participants. Assessments of pain, disease activity, and antidepressant medication use were collected from the patient and provider. Results indicated that depression might be underdiagnosed in pediatric lupus patients. While psychotropic medication and pain scores were independently related to greater patient-provider discordance regarding health status, pain mediated this relationship. Implications for treatment outcomes are discussed.


2014 ◽  
Vol 17 (6) ◽  
pp. 493-501 ◽  
Author(s):  
Georgia D. Walton ◽  
Lori E. Ross ◽  
Donna E. Stewart ◽  
Sophie Grigoriadis ◽  
Cindy-Lee Dennis ◽  
...  

2013 ◽  
Vol 44 (6) ◽  
pp. 1205-1212 ◽  
Author(s):  
K. Manderbacka ◽  
M. Jokela ◽  
R. Sund ◽  
M. Elovainio

BackgroundThis study examined two competing hypotheses concerning the association between diabetes and treatment for depression: (1) the detection/ascertainment bias hypothesis suggesting that those with diabetes are more likely to be diagnosed with and treated for depression because of increased medical attention and (2) a hypothesis assuming that diabetes and depression share common underlying pathophysiological pathways.MethodThe study population included all persons aged 35–65 years in Finland with any record of type 2 diabetes in the national health and population registers from 1999 to 2002 and for whom register-based data on depression treatment (antidepressant medication use and hospitalizations for depression) were available at least 2 years before and after the diagnosis of diabetes (n = 18 217). Sociodemographic data were individually linked to the study population. Associations between diabetes diagnosis and time and indicators of depression care were assessed with population-averaged multilevel logistic models.ResultsWithin the year following diagnosis diabetes, there was a 5% increase in antidepressant medication use but not in hospitalization for depression. The longitudinal change in antidepressant use over time was less steep after the diabetes diagnosis, and hospitalization risk decreased after the diagnosis. These associations between diabetes diagnosis and depression treatment were not modified by the participant's socio-economic position (SEP).ConclusionsThese findings support the common cause hypothesis that treatment for diabetes is beneficial to the prevention of depression rather than the detection/ascertainment hypothesis that individuals with diabetes have higher rates of depression because they receive more medical attention in general.


Sign in / Sign up

Export Citation Format

Share Document